Latest Leadership Change News

Arovella Therapeutics secured ethics approval and manufactured its first clinical batch of ALA-101, targeting blood cancers, while progressing its solid tumour program and refining autoimmune strategies. The company ended the quarter with $14.4 million in cash, supporting imminent clinical milestones.

Proteomics International Laboratories has streamlined operations, secured a key US patent for its endometriosis test, and inked a three-year exclusive distribution deal with Healius for its Promarker diagnostics in Australia.

Imugene's azer-cel therapy shows a third patient response in the BTKi combination cohort of its Phase 1b trial, while CEO Leslie Chong steps down after nearly 11 years, prompting a leadership search.

Conrad Asia Energy has locked in over 90% of its US$320 million Mako Gas Project contracts, maintaining its timeline for first gas in late 2027 while restructuring leadership and progressing Aceh PSC assets.

LinQ Minerals has delivered significant drilling results at its Gilmore Project, confirming a large shallow copper-gold porphyry system at Monza and extending high-grade gold-copper mineralisation at Dam. With a strong cash position and multiple assay results pending, the company is well placed for further exploration.

Spark New Zealand restructures into Connectivity and Digital Services divisions, initiating a strategic review of its Digital Services arm to explore shareholder value maximisation. Leadership changes accompany the move, while FY26 guidance remains steady.

BOA Resources has secured full ownership of Core Value Australia NL, adding the Thaduna and Green Dragon copper deposits to its Neds Creek portfolio and gearing up for a 15,000m maiden drilling campaign.

Cycliq Group delivered steady quarterly receipts and returned to net operating cash inflow in Q4 FY2026, driven by a robust End of Financial Year sales campaign and strategic appointments aimed at expanding AI capabilities.

I Synergy Group has appointed Anson Heng as Executive Chairman and Managing Director to spearhead its strategic cooperation with Macau Direch, formalised through a non-binding MoU targeting blockchain, AI, and digital asset initiatives.

Genetic Signatures has completed a major restructure delivering $5 million in annual savings from FY2027 and secured a decade-long supply contract with Denmark’s Hvidovre Hospital, while posting $14.8 million revenue for FY2026 amid market pressures.

Latrobe Magnesium (ASX: LMG) is set for leadership change with Robert Stein stepping in as CEO from October 2026, while Peter Mizera takes charge of the Construction Committee, underpinning the company’s push towards magnesium metal production.

The Federal Court found Domino’s liable for misleading conduct over historical pay agreements, awarding underpayment to the lead plaintiff. Wider claims remain unresolved amid ongoing legal uncertainty.